-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Voyager Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
- Voyager Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.8M, a 53.3% increase year-over-year.
- Voyager Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $9.08M, a 79.1% decline year-over-year.
- Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $122M.
- Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$50.8M, a 30.9% increase from 2021.
- Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$73.6M, a 369% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)